The Gordon Center for Medical Imaging at Massachusetts General Hospital (MGH) and Harvard Medical School is a multidisciplinary research center dedicated to improving patient care by developing and promoting new biomedical imaging technologies used in both diagnosis and therapy.
Our main activities include research, training, and translation of innovative research into clinical applications. Investigators from the academic community, research laboratories, and industry are welcome to use the Center’s medical imaging equipment and clinical research facilities available through PET Core.
Created in 2015 with an endowment from the Bernard and Sophia Gordon Foundation, the Gordon Center for Medical Imaging is a direct continuation of MGH’s Division of Radiological Sciences where the first positron-imaging device was invented. As early as the 1950s, a series of important milestones were achieved at MGH, including the MGH-positron (2D) cameras, the filtered backprojection algorithm (Chesler) and multiple gated cardiac imaging (Alpert).
Today, the Gordon Center focuses on research, translation to clinical application and training of the next generation of scientists and engineers in medical imaging. These activities stress academic research sponsored by federal agencies and industrial collaborations. Predoctoral students and postdoctoral fellows gain experience, mainly aimed toward fostering their academic careers, by participating in ongoing research, educational symposia and tutorials. In parallel, promising scientists and engineers, who are interested in combining entrepreneurship, engineering and academic research in support of the public good, can benefit from the Center’s support to translate their transformative research.
Upcoming Seminars and Events
Our research spans a variety of imaging modalities from CT to PET to MRI to optical. We have expertise in a variety of techniques from reconstruction and kinetic modeling to radiotracer development
The MGH Gordon PET Core is cGMP/FDA registered positron emission tomography drug manufacturer that operates at cost to provide investigators with services to design and conduct research studies.